Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-31

FDA Approved: IBUPROFEN PM — Original Application (KROGER COMPANY)

View source ↗

Summary

FDA approved Kroger's Ibuprofen PM, an over-the-counter combination product containing ibuprofen and diphenhydramine citrate, under an original ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diphenhydramine citrate (diphenhydramine citrate)
  • Ibuprofen (IBUPROFEN)

Snippet

ORIG AP for IBUPROFEN PM (IBUPROFEN AND DIPHENHYDRAMINE CITRATE)